Header and Body 2

Problem Addressed

There is currently a lack of accurate and readily available devices to quantitatively monitor alcohol intake and frequency among the millions of Americans with alcohol use disorder. While a few can provide point-of-care alcohol intake monitoring (e.g., transdermal and breath alcohol sensors), these options only measure secondary information from metabolized alcohol, and are thus limited in their ability to accurately provide real-time quantitative measurements to support effective and continuous therapeutic intervention.